Tiwari Rupali S, Deshpande Nupoor, Mundada Bhushan, Reche Amit, Madhu Priyanka Paul, Ranit Pranoti Pramod, Kotewar Samrudhi S
Department of Oral and Maxillofacial Surgery, Shri Sharad Pawar Dental College and Hospital, Datta Meghe Institute of Medical Sciences (Deemed to be University) Sawangi (Meghe), Wardha, Maharashtra, India.
Department of Public Health Dentistry, Shri Sharad Pawar Dental College and Hospital, Datta Meghe Institute of Medical Sciences (Deemed to be University) Sawangi (Meghe), Wardha, Maharashtra, India.
Natl J Maxillofac Surg. 2025 Jan-Apr;16(1):98-103. doi: 10.4103/njms.njms_67_23. Epub 2025 Apr 28.
The extraction of impacted third molars is now a standard procedure for oral surgeons. However, it also presents with postoperative sequelae that are difficult for the patients to handle. Hence, to overcome these complications, the present study compares the efficacy of laser therapy and triamcinolone acetonide to find the best treatment modality for patients with such difficulties.
A prospective, randomized clinical trial was carried out on 60 patients aged 18-30 years requiring impacted third molar extraction. The subjects were grouped into two ( = 30 for each group) to assess pain, trismus, and edema. One group was provided with laser treatment with a continuous wavelength of 650 nm at an energy density of 1.26 J/cm and output power of 0.3 W for 60 sec, and the other with triamcinolone acetonide 40 mg/ml postoperatively on day two and 20 mg/ml postoperatively on day seven intraorally into buccal mucosa over the masseter muscle. The assessment was done for days 2 and 7. Statistical Package for Social Sciences version 24.0 was used for data analysis, and the statistical significance established was < 0.05.
After assessment for pain, edema, and trismus, complications were reduced from day two to day seven when the two treatment modalities had statistical differences. It was found that the triamcinolone group had more reduction in complications than the laser group.
In its limitations, the study concluded that triamcinolone acetonide acts as a better treatment modality than laser treatment during an assessment.
拔除阻生第三磨牙目前是口腔外科医生的常规操作。然而,术后后遗症也给患者带来了困扰。因此,为克服这些并发症,本研究比较了激光治疗和曲安奈德的疗效,以找出针对此类患者的最佳治疗方式。
对60例年龄在18至30岁之间需要拔除阻生第三磨牙的患者进行了一项前瞻性随机临床试验。将受试者分为两组(每组 = 30例),以评估疼痛、张口受限和水肿情况。一组接受波长为650 nm的连续激光治疗,能量密度为1.26 J/cm,输出功率为0.3 W,持续60秒;另一组在术后第二天经口腔向咬肌上方颊黏膜注射40 mg/ml曲安奈德,术后第七天注射20 mg/ml。在第2天和第7天进行评估。使用社会科学统计软件包第24.0版进行数据分析,设定的统计学显著性为 < 0.05。
在对疼痛、水肿和张口受限进行评估后发现,从第2天到第7天,两种治疗方式存在统计学差异时,并发症有所减少。结果发现,曲安奈德组的并发症减少程度比激光组更大。
尽管存在局限性,但该研究得出结论,在评估期间,曲安奈德作为一种治疗方式比激光治疗效果更好。